# An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations

> **NCT02934698** · PHASE3 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 2 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Ivacaftor

## Key facts

- **NCT ID:** NCT02934698
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2018-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934698, "An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02934698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*